MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Enzo Biochem Company Profile (NYSE:ENZ)

Consensus Ratings for Enzo Biochem (NYSE:ENZ) (?)
Ratings Breakdown: 1 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: N/A

Analysts' Ratings History for Enzo Biochem (NYSE:ENZ)
Show:
DateFirmActionRatingPrice TargetActions
2/9/2016Dawson JamesReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 6/28/2014 forward)
Earnings History for Enzo Biochem (NYSE:ENZ)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
6/8/2016        
6/8/2016Q316($0.06)($0.04)$24.50 million$18.16 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/9/2016Q216($0.06)($0.07)$24.43 million$24.60 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
12/7/2015Q116($0.05)($0.05)$25.20 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/13/2015Q415($0.06)($0.06)$24.60 million$25.70 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
6/9/2015Q315($0.06)($0.07)$24.40 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/12/2015Q215($0.09)($0.09)$23.10 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
12/9/2014Q114($0.08)($0.08)$24.50 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/9/2014($0.07)($0.06)ViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
6/9/2014Q314($0.09)($0.01)$22.80 million$24.00 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/11/2014Q2($0.08)($0.09)$22.00 million$22.93 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
12/11/2013Q1($0.06)($0.07)ViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/16/2013Q413($0.08)$22.00 million$23.30 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
6/10/2013Q3 2013($0.15)$22.20 million$22.60 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)
Earnings Estimates for Enzo Biochem (NYSE:ENZ)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20161($0.06)($0.06)($0.06)
Q3 20161($0.05)($0.05)($0.05)
(Data provided by Zacks Investment Research)
Dividend History for Enzo Biochem (NYSE:ENZ)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trading History for Enzo Biochem (NYSE:ENZ)
No insider trades for this company have been tracked by MarketBeat.com

Latest Headlines for Enzo Biochem (NYSE:ENZ)
DateHeadline
06/27/16 03:50 PMENZO BIOCHEM INC Files SEC form 8-K, Other Events -
06/27/16 03:48 PMEnzo Biochem : Added To Russell 2000, Russell 3000 and Russell Global Indexes
06/27/16 06:30 AMEnzo Biochem Added To Russell 2000, Russell 3000 and Russell Global Indexes - [Business Wire] - Enzo Biochem announced that it has been included in the broad-market Russell 3000® Index, Russell 2000® Index and Russell Global Index, which reconstituted after the market closed on Friday, June 24th.
06/25/16 03:40 PMEnzo Biochem, Inc. (NYSE:ENZ) Yearly Accounts Payable At $8.762 Millions - RealistInvestor.com
06/25/16 03:40 PMStrong Sell Calls Recommendations For Enzo Biochem, Inc. (NYSE:ENZ) At 0 - Investor Newswire
06/25/16 03:40 PMAnalysts Ranking Previews: Enzo Biochem, Inc. (NYSE:ENZ) , Inovio Pharmaceuticals, Inc. (NASDAQ:INO) - Street Updates
06/24/16 10:38 AMGlobal Osteonecrosis Pipeline Report 2016 - Therapeutics Review of Bone Therapeutics, Enzo Biochem, & K-Stemcell Co. - Research and Markets
06/24/16 08:55 AMEdited Transcript of ENZ earnings conference call or presentation 8-Jun-16 12:30pm GMT -
06/23/16 08:54 PMTraders Are Bullish Enzo Biochem, Inc. After Today's Gap Up - Press Telegraph
06/23/16 05:49 AMEnzo Biochem, Inc. (NYSE:ENZ) Current Analyst Ratings - Fiscal Standard
06/23/16 05:49 AMEnzo Biochem Inc. (NYSE:ENZ) Stock Momentum Hits Strength - CML News
06/22/16 03:58 PMOsteonecrosis Pipeline Market Global Stage and Molecule Types
06/22/16 08:33 AMOxidative Stress Assay 2016 Global Market Opportunities and Forecasts 2022
06/21/16 03:39 PMUveitis Treatment Market - Asia to Witness Fastest Growth by 2020
06/19/16 08:13 AMEnzo Biochem, Inc. (NYSE:ENZ) Accounts Payable Is $9.152 For The Quarter Ended 2016-04-30 - RealistInvestor.com
06/19/16 08:13 AMStrong Buy Calls Count For Enzo Biochem, Inc. (NYSE:ENZ) At 1 - Investor Newswire
06/15/16 08:34 AMEnzo Biochem Inc. ($0.01 Par Value) (ENZ) Drops 5.01% on June 13 - Equities.com
06/11/16 12:04 PMENZO BIOCHEM INC Financials -
06/10/16 07:21 AMEnzo Biochem Inc. ($0.01 Par Value) (ENZ) is Trading Higher on Unusual Volume for June 08 - Equities.com
06/09/16 07:56 AMEnzo Biochem (ENZ) Q3 2016 Results - Earnings Call Transcript - Seeking Alpha
06/09/16 07:56 AMEnzo Biochem Inc. ($0.01 Par Value) (ENZ) is Trading Lower on Unusual Volume for June 07 - Equities.com
06/08/16 04:00 PMBRIEF-Enzo Biochem Q3 non-gaap loss per share $0.04 - Reuters
06/08/16 04:00 PMEnzo Biochem Reports Fiscal Third Quarter Results - Business Wire (press release)
06/08/16 08:11 AMEnzo Biochem Reports Fiscal Third Quarter Results
06/08/16 07:01 AMENZO BIOCHEM INC Files SEC form 8-K, Results of Operations and Financial Condition, Regulation FD Disclosure -
06/08/16 06:43 AMEnzo Biochem reports 3Q loss -
06/07/16 03:56 PMPseudomonas Diagnostic Testing Market Research Report : Forecast 2015 - 2021
06/07/16 03:56 PMResearch focused on the osteoporosis pipeline market review 2016
06/07/16 03:56 PMENZO BIOCHEM INC : Other Events (form 8-K)
06/07/16 03:56 PMEnzo Biochem Announces New York State Approval of New Women's Test Based on Proprietary Technology
06/03/16 03:25 PMEnzo Biochem Schedules Teleconference to Discuss Third Quarter 2016 Results Wednesday, June 8, 2016 at 8:30 AM E.T. - [Business Wire] - Enzo Biochem, Inc. , will hold a conference call to discuss fiscal 2016 third quarter results, Wednesday, June 8, 2016, at 8:30 AM E.T.
06/03/16 07:55 AMNew report examines the global central nervous system (cns) biomarkers market : global industry information, market size and forecast 2016 - Abastar MDX Inc, Thermo fisher scientific, Abiant Inc, EKFdiagnostics holdings Inc, Enzo biochem Inc, Acumen pharmaceuticals Inc, Adlyfe Inc, Alseres pharmaceuticals Inc, Apitope international, Aposense, Applied neurosolutions Inc, Avacta group plc ...
06/01/16 07:50 AMType 2 Diabetes Market Pipeline Covering 221 Companies for H1 2016 Reviewed in New Research Report - Inc, Enzo Biochem, Inc., Epichem Pty Ltd, Esperion Therapeutics, Inc., Eternygen GmbH, Euroscreen S.A., Evotec AG, F. Hoffmann-La Roche Ltd., FibroStatin SL, Flamel Technologies S.A., Foresee Pharmaceuticals, LLC, Generex Biotechnology Corporation ...
05/25/16 01:20 PMEnzo Biochem, Inc. (NYSE:ENZ) Closes At $6.17 - Investor Newswire - Enzo Biochem, Inc. (NYSE:ENZ) Closes At $6.17Investor NewswireYesterday, the stock of Enzo Biochem, Inc. (NYSE:ENZ) closed at $6.17 after opening at $6.21 and registering high of $6.38 and low of $6.00. The last price is $-0.12 off 1-year high of $6.47 and $4.09 away from low of $2.26 during same period. This ...Enzo Biochem Incorporated (NYSE:ENZ) Shorted Shares Increased 1.19% After Market SellingThe PostBroker Roundup For Enzo Biochem, Inc. (NYSE:ENZ)Share Trading Newsall 3 news articles »
05/23/16 04:07 PMETF’s with exposure to Enzo Biochem, Inc. : May 23, 2016 -
05/20/16 01:31 PMEnzo Biochem Inc. (ENZ) is Trading Higher on Unusual Volume for May 18 - Equities.com - Enzo Biochem Inc. (ENZ) is Trading Higher on Unusual Volume for May 18Equities.comEnzo Biochem Inc. (ENZ) experienced unusually high volume on May. 18, as the stock gained 0.48% to a closing price of $6.23. The stock saw 410,724 shares trade hands over the course of the day on 2,263 trades. Given that the stock's average daily ...Enzo Biochem, Inc. (NYSE:ENZ) Updated Broker Price TargetsShare Trading Newsall 2 news articles »
05/19/16 01:08 PMEnzo Biochem Inc. (ENZ) is Trading Higher on Unusual Volume for May 17 - Equities.com - Enzo Biochem Inc. (ENZ) is Trading Higher on Unusual Volume for May 17Equities.comEnzo Biochem Inc. (ENZ) experienced unusually high volume on May. 17, as the stock gained 1.81% to a closing price of $6.20. The stock saw 306,183 shares trade hands over the course of the day on 1,931 trades. Given that the stock's average daily ...
05/18/16 01:50 PMEnzo Biochem Inc. (ENZ) is Trading Higher on Unusual Volume for May 16 - Equities.com - Enzo Biochem Inc. (ENZ) is Trading Higher on Unusual Volume for May 16Equities.comEnzo Biochem Inc. (ENZ) experienced unusually high volume on May. 16, as the stock gained 0.66% to a closing price of $6.09. The stock saw 392,252 shares trade hands over the course of the day on 2,091 trades. Given that the stock's average daily ...Upgrades And Downgrades For Enzo Biochem, Inc. (NYSE:ENZ)Risers & FallersEnzo Biochem (ENZ) Announces $35M Patent Infringement Settlement with Life Technologies (TMO)StreetInsider.comLatest Analyst Ratings For Enzo Biochem, Inc. (NYSE:ENZ)Share Trading NewsEnterprise Leader -Finance Dailyall 10 news articles »
05/18/16 01:50 PMEnzo Biochem Inc. (ENZ) Hits New 52-week High During May 16 Session - Equities.com - Enzo Biochem Inc. (ENZ) Hits New 52-week High During May 16 SessionEquities.comEnzo Biochem Inc. (ENZ) hit a new 52-week high yesterday, reaching a peak of $6.47 after opening at $6.10 and closing at $6.09 for a move of 0.66%. Hitting a new 52-week high is a notable milestone for any company, and it can mean a trading opportunity ...and more »
05/17/16 02:03 PMHealthcare New Highs: IRIDEX Corporation (NASDAQ:IRIX), Enzo Biochem Inc. (NYSE:ENZ), Emergent BioSolutions ... - KC Register - Healthcare New Highs: IRIDEX Corporation (NASDAQ:IRIX), Enzo Biochem Inc. (NYSE:ENZ), Emergent BioSolutions ...KC RegisterEnzo Biochem Inc. (NYSE:ENZ) announced that its subsidiary, Enzo Life Sciences, Inc., has reached and finalized a settlement with Life Technologies Corporation, a subsidiary of Thermo Fisher Scientific Inc. (NYSE:TMO), involving payment of $35 million ...and more »
05/17/16 02:03 PMThermo Fisher To Pay $35M In Enzo DNA Patent Row - Law360, Los Angeles (May 16, 2016, 9:32 PM ET) -- A unit of Thermo Fisher Scientific Inc. will pay $35 million to a unit of Enzo Biochem Inc. to end a years-long patent infringement fight in Delaware federal court over a pair of DNA testing patents ...
05/17/16 02:03 PMENZO BIOCHEM INC : Other Events, Financial Statements and Exhibits (form 8-K) - 10:08p ENZO BIOCHEM: Life Sciences Unit Reaches $35 Million Patent Infringement Settle.. 03/17 ENZO BIOCHEM: Submits AmpiProbe Based Assay Targeted at Women's Health for Appr.. 03/11 ENZO BIOCHEM: Submits Ampiprobe™ Based Assay Targeted At Women's Health f.
05/17/16 02:03 PMEnzo Biochem (ENZ) Announces $35M Patent Infringement Settlement with Life Technologies (TMO) - Get inside Wall Street with StreetInsider Premium. Claim your 2-week free trial here. Enzo Biochem, Inc. (NYSE: ENZ) today announced that its subsidiary, Enzo Life Sciences, Inc., has reached and finalized a settlement with Life Technologies Corporation ...
05/17/16 02:03 PMEnzo Biochem, Inc. Pipeline Review, Market Size, Market Analysis and Forecast 2016 to 2020 - “Enzo Biochem, Inc. Global 2015 Clinical Trials Review, H2” provides an detailed overview of Enzo Biochem, Inc. scenario. Report includes top line data relating on Enzo Biochem, Inc. Global clinical trials scenario. This report on Enzo Biochem, Inc ...
05/16/16 04:28 PMENZO BIOCHEM INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits -
05/16/16 03:08 PM4:08 pm Enzo Biochem reaches finalized settlement w/ Thermo Fisher Scientific (TMO)), involving payment of $35 million to co in patent infringement case -
05/16/16 03:07 PMEnzo Biochem’s Life Sciences Unit Reaches $35 Million Patent Infringement Settlement in Delaware With Life Technologies Corporation - [Business Wire] - Enzo Biochem, Inc. today announced that its subsidiary, Enzo Life Sciences, Inc., has reached and finalized a settlement with Life Technologies Corporation, a subsidiary of Thermo Fisher Scientific Inc.
05/13/16 07:47 AMServices Trending Stocks at the Close - Envirostarm Inc (EVI)- The company’s shares advanced 4.71 pct. Mimecast Limited Ord (MIME)- The company’s shares rose 4.19 pct. Enzo Biochem (ENZ)- The company’s shares advanced 3.05 pct. Engility Holdings Inc. Common (EGL)- The company’s stocks ...
05/12/16 08:01 AMEnzo Biochem Inc. (ENZ) is Trading Lower on Unusual Volume for May 10 - Equities.com - Washington News WireEnzo Biochem Inc. (ENZ) is Trading Lower on Unusual Volume for May 10Equities.comEnzo Biochem Inc. (ENZ) experienced unusually high volume on May. 10, as the stock lost 1.84% to a closing price of $5.88. The stock saw 554,968 shares trade hands over the course of the day on 3,190 trades. Given that the stock's average daily volume ...Analysts Anticipate Enzo Biochem, Inc. (NYSE:ENZ) to Announce ($0.06) Earnings Per ShareWashington News WireCould Enzo Biochem, Inc. Skyrocket Even More? The Stock Just Made 52-Week HighThe PostEnzo Biochem, Inc. (NYSE:ENZ) Latest Broker ViewsRisers & FallersFinance Dailyall 7 news articles »
05/12/16 08:01 AMEnzo Biochem Inc. (ENZ) Hits New 52-week High During May 10 Session - Equities.com - Enzo Biochem Inc. (ENZ) Hits New 52-week High During May 10 SessionEquities.comEnzo Biochem Inc. (ENZ) hit a new 52-week high yesterday, reaching a peak of $6.00 after opening at $6.00 and closing at $5.88 for a move of -1.84%. Hitting a new 52-week high is a notable milestone for any company, and it can mean a trading ...and more »
About Enzo Biochem

Enzo Biochem logoEnzo Biochem, Inc. (Enzo) is an integrated life science and biotechnology company, which is engaged in the research, development, manufacturing and marketing of diagnostic and research products based on genetic engineering, biotechnology and molecular biology. These products are designed for the diagnosis of and/or screening for infectious diseases, cancers, genetic defects and other medically pertinent diagnostic information and are distributed in the United States and internationally. The Company operates through three segments: Enzo Life Sciences, Enzo Clinical Labs and Enzo Therapeutics. Enzo Life Sciences segment manufactures, develops and markets products and tools to clinical research, drug development and bioscience research customers around the world. Enzo Clinical Labs segment provides diagnostic services to the healthcare community. Enzo Therapeutics segment conducts research and development activities for therapeutic drug candidates.

Industry, Sector and Symbol:
  • Sector: Healthcare
  • Industry: Medical Laboratories & Research
  • Sub-Industry: N/A
  • Exchange: NYSE
  • Symbol: ENZ
  • CUSIP:
Key Metrics:
  • Previous Close: $5.68
  • 50 Day Moving Average: $6.00
  • 200 Day Moving Average: $4.97
  • P/E Ratio: 14.87
  • P/E Growth: 0.00
  • Market Cap: $262.78M
  • Current Quarter EPS Consensus Estimate: $-0.23 EPS
Additional Links:
Enzo Biochem (NYSE:ENZ) Chart for Tuesday, June, 28, 2016


            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha